誉衡药业 (002437.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(誉衡药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 2,626,039,306.712,052,008,504.701,432,663,200.48681,168,970.963,107,945,160.602,415,056,804.711,599,568,666.45774,211,987.48
 营业利润(元) 175,046,611.96260,409,694.6751,371,381.1632,216,202.85-270,085,357.1068,551,776.6756,914,849.5815,446,773.42
 利润总额(元) 176,778,148.92260,197,852.8351,380,819.8332,013,464.93-269,678,552.7067,798,541.3656,107,626.4214,706,825.16
 净利润(元) 128,700,640.73231,061,077.3232,283,048.3221,870,444.70-289,517,719.0937,305,467.3031,797,036.123,046,070.09
 归属于母公司股东的净利润(元) 120,334,186.37223,623,549.8528,249,027.2520,058,598.74-291,328,832.9230,104,826.1526,870,523.13998,263.43
盈利能力:
 销售毛利率(%) 58.3978.6279.0178.4476.8676.7875.1375.67
 销售净利率(%) 4.9011.262.253.21-9.321.541.990.39
 净资产收益率(%) 7.3112.021.581.13----
 总资产报酬率ROA(%) 5.767.111.801.12----
 投入资本回报率ROIC(%) 4.447.870.980.66-8.770.850.760.03
营运能力:
 存货周转率(次) 5.401.891.240.52----
 应收账款周转率(次) 12.1110.266.023.27----
 总资产周转率(次) 0.730.510.350.16----
偿债能力:
 资产负债率(%) 45.7547.8052.2956.6158.1955.4155.9156.28
 股东权益比率(%) 52.7150.2845.9241.8040.0442.8042.1341.80
 已获利息倍数(倍) 6.6510.763.293.07-4.773.133.061.81
 流动比率 0.820.920.790.790.780.810.780.83
 速动比率 0.680.780.670.680.670.690.660.68
发展能力:
 营业收入增长率(%) -15.51-15.03-10.43-12.02-1.194.184.049.78
 营业利润增长率(%) 164.81279.87-9.74108.56-381.65-56.25-62.29-59.07
 税后利润增长率(%) 141.31642.825.131,909.35-746.79-72.76-76.55-95.44
 净资产增长率(%) 1.87-7.27-13.65-12.90-13.88-1.39-1.871.40
 总资产增长率(%) -22.62-21.07-20.77-12.90-13.23-9.79-7.22-6.92

前瞻产业研究院